{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:18:56Z","timestamp":1791537536568,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To evaluate patient-reported effectiveness, safety and social influence of Pamidronate in the therapy of NSAIDs-refractory Chronic Recurrent Multifocal Osteomyelitis in children. Authors reviewed self-created questionnaires, which asked patients for symptoms alleviation, adverse drug reactions frequency and degree of severity and daily activities self-reliance. Only surveys with complete answers, which were returned to authors by an e-mail from juvenile patients treated for NSAIDs-refractory Chronic Recurrent Multifocal Osteomyelitis at the University Children\u2019s Hospital of Cracow were analyzed. Between 2010 and 2019, 61 children were diagnosed with NSAIDs-refractory Chronic Recurrent Multifocal Osteomyelitis at our department. Out of 61 requests sent, 42 complete replies (33 females, 9 males) were gathered and analyzed. All patients included in this research were administered with at least one set of Pamidronate intravenously in the dose of 1\u00a0mg\/kg\/day for 3 consecutive days. Our analysis shows remarkable in terms of patient\u2019s impressions decrease of pain intensity after 2.5 series of Pamidronate on average, and total pain resolution after 5.9 series on average. Overall number of adverse drug reaction events reported by responders was 105. One patient developed drug-dependent renal insufficiency in the course of therapy. Outcome assessment indicates that nearly 50% of the studied population was more eager to participate in social life just after the first infusion of the drug. 95% of the surveyed unanimously agreed to recommend Pamidronate therapy to cure NSAIDs-refractory CRMO. 39 out of 42 (93%) patients considered Pamidronate effective at the end of the treatment. Onset of Pamidronate\u2019s action is gradual and differs in terms of symptoms alleviation between sexes. The therapy can induce considerable number of adverse drug reactions (2.5 per patient). Only 3 out of 42 (7%) patients were free from any ADRs. To demonstrate the impact of the use of Pamidronate on daily activities more precisely, further research with quantification of the quality of life is warranted.<\/jats:p>","DOI":"10.1007\/s00296-021-04886-4","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T12:03:03Z","timestamp":1621512183000},"page":"699-706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2200-9527","authenticated-orcid":false,"given":"Bart\u0142omiej","family":"Juszczak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4609-3436","authenticated-orcid":false,"given":"Jerzy","family":"Su\u0142ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"issue":"3","key":"4886_CR1","first-page":"329","volume":"15","author":"A Giedion","year":"1972","unstructured":"Giedion A, Holthusen W, Masel LF, Vischer D (1972) Subacute and chronic \u201csymmetrical\u201d osteomyelitis. Ann Radiol (Paris) 15(3):329\u2013342","journal-title":"Ann Radiol (Paris)"},{"issue":"1","key":"4886_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40348-017-0073-y","volume":"4","author":"SR Hofmann","year":"2017","unstructured":"Hofmann SR, Kapplusch F, M\u00e4bert K, Hedrich CM (2017) The molecular pathophysiology of chronic non-bacterial osteomyelitis (CNO)\u2014a systematic review. Mol Cell Pediatr 4(1):7. https:\/\/doi.org\/10.1186\/s40348-017-0073-y","journal-title":"Mol Cell Pediatr"},{"issue":"3","key":"4886_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.clim.2012.12.012","volume":"147","author":"H Morbach","year":"2013","unstructured":"Morbach H, Hedrich CM, Beer M, Girschick HJ (2013) Autoinflammatory bone disorders. Clin Immunol 147(3):185\u2013196. https:\/\/doi.org\/10.1016\/j.clim.2012.12.012","journal-title":"Clin Immunol"},{"issue":"2","key":"4886_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.clim.2015.09.013","volume":"161","author":"SR Hofmann","year":"2015","unstructured":"Hofmann SR, Kubasch AS, Ioannidis C, R\u00f6sen-Wolff A, Girschick HJ, Morbach H, Hedrich CM (2015) Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1\u03b2 expression and release. Clin Immunol 161(2):300\u2013307. https:\/\/doi.org\/10.1016\/j.clim.2015.09.013","journal-title":"Clin Immunol"},{"issue":"1","key":"4886_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.clim.2012.07.012","volume":"145","author":"SR Hofmann","year":"2012","unstructured":"Hofmann SR, Morbach H, Schwarz T, R\u00f6sen-Wolff A, Girschick HJ, Hedrich CM (2012) Attenuated TLR4\/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression. Clin Immunol 145(1):69\u201376. https:\/\/doi.org\/10.1016\/j.clim.2012.07.012","journal-title":"Clin Immunol"},{"key":"4886_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1546-0096-12-30","volume":"12","author":"R Scianaro","year":"2014","unstructured":"Scianaro R, Insalaco A, Bracci Laudiero L, De Vito R, Pezzullo M, Teti A et al (2014) Deregulation of the IL-1beta axis in chronic recurrent multifocal osteomyelitis. Pediatr Rheumatol Online J 12:30. https:\/\/doi.org\/10.1186\/1546-0096-12-30","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"4886_CR7","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/art.24402","volume":"60","author":"AF Jansson","year":"2009","unstructured":"Jansson AF, M\u00fcller TH, Gliera L, Ankerst DP, Wintergerst U, Belohradsky BH, Jansson V (2009) Clinical score for nonbacterial osteitis in children and adults. Arthritis Rheum 60(4):1152\u20131159. https:\/\/doi.org\/10.1002\/art.24402","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4886_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s004310050761","volume":"157","author":"HJ Girschick","year":"1998","unstructured":"Girschick HJ, Krauspe R, Tschammler A, Huppertz HI (1998) Chronic recurrent osteomyelitis with clavicular involvement in children: diagnostic value of different imaging techniques and therapy with non-steroidal anti-inflammatory drugs. Eur J Pediatr 157(1):28\u201333. https:\/\/doi.org\/10.1007\/s004310050761","journal-title":"Eur J Pediatr"},{"issue":"2","key":"4886_CR9","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/ar2992","volume":"12","author":"C Beck","year":"2010","unstructured":"Beck C, Morbach H, Beer M, Stenzel M, Tappe D, Gattenl\u00f6hner S, Hofmann U, Raab P, Girschick HJ (2010) Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther 12(2):R74. https:\/\/doi.org\/10.1186\/ar2992","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"4886_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1546-0096-11-47","volume":"11","author":"CM Hedrich","year":"2013","unstructured":"Hedrich CM, Hofmann SR, Pablik J, Morbach H, Girschick HJ (2013) Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J 11(1):47. https:\/\/doi.org\/10.1186\/1546-0096-11-47","journal-title":"Pediatr Rheumatol Online J"},{"issue":"8","key":"4886_CR11","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/acr.23462","volume":"70","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu EY, Oliver MS, Cooper AM, Basiaga ML, Vora SS, Lee TC, Fox E (2018) Consensus treatment plans for chronic nonbacterial osteomyelitis refractory to nonsteroidal anti-inflammatory drugs and\/or with active spinal lesions. Arthritis Care Res 70(8):1228\u20131237. https:\/\/doi.org\/10.1002\/acr.23462","journal-title":"Arthritis Care Res"},{"issue":"6","key":"4886_CR12","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jbspin.2019.06.005","volume":"86","author":"J Su\u0142ko","year":"2019","unstructured":"Su\u0142ko J, Ebisz M, Bie\u0144 S, B\u0142a\u017ckiewicz M, Jurczyk M, Namy\u015blak M (2019) Treatment of chronic recurrent multifocal osteomyelitis with bisphosphonates in children. Joint Bone Spine 86(6):783\u2013788. https:\/\/doi.org\/10.1016\/j.jbspin.2019.06.005","journal-title":"Joint Bone Spine"},{"issue":"4","key":"4886_CR13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jpeds.2007.08.047","volume":"152","author":"PJ Simm","year":"2008","unstructured":"Simm PJ, Allen RC, Zacharin MR (2008) Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis. J Pediatr 152(4):571\u2013575. https:\/\/doi.org\/10.1016\/j.jpeds.2007.08.047","journal-title":"J Pediatr"},{"key":"4886_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1546-0096-7-2","volume":"7","author":"PM Miettunen","year":"2009","unstructured":"Miettunen PM, Wei X, Kaura D, Reslan WA, Aguirre AN, Kellner JD (2009) Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J 7:2. https:\/\/doi.org\/10.1186\/1546-0096-7-2","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"4886_CR15","first-page":"707","volume":"35","author":"H Gleeson","year":"2008","unstructured":"Gleeson H, Wiltshire E, Briody J, Hall J, Chaitow J, Sillence D, Cowell C, Munns C (2008) Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape. J Rheumatol 35(4):707\u2013712","journal-title":"J Rheumatol"},{"issue":"45","key":"4886_CR16","doi-asserted-by":"publisher","first-page":"e398","DOI":"10.3346\/jkms.2020.35.e398","volume":"35","author":"PS Gaur","year":"2020","unstructured":"Gaur PS, Zimba O, Agarwal V, Gupta L (2020) Reporting Survey Based Studies \u2013 a Primer for Authors. J Korean Med Sci 35(45):e398. https:\/\/doi.org\/10.3346\/jkms.2020.35.e398","journal-title":"J Korean Med Sci"},{"key":"4886_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12969-017-0216-7","volume":"15","author":"A Taddio","year":"2017","unstructured":"Taddio A, Ferrara G, Insalaco A et al (2017) Dealing with chronic non-bacterial osteomyelitis: a practical approach. Pediatr Rheumatol 15:87. https:\/\/doi.org\/10.1186\/s12969-017-0216-7","journal-title":"Pediatr Rheumatol"},{"issue":"7","key":"4886_CR18","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1111\/apa.13420","volume":"105","author":"S Pastore","year":"2016","unstructured":"Pastore S, Ferrara G, Monasta L, Meini A, Cattalini M, Martino S, Alessio M, La Torre F, Teruzzi B, Gerloni V, Breda L, Taddio A, Lepore L (2016) Chronic nonbacterial osteomyelitis may be associated with renal disease and bisphosphonates are a good option for the majority of patients. Acta Paediatr 105(7):e328\u2013e333. https:\/\/doi.org\/10.1111\/apa.13420","journal-title":"Acta Paediatr"},{"issue":"7","key":"4886_CR19","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/rheumatology\/key058","volume":"57","author":"H Girschick","year":"2018","unstructured":"Girschick H, Finetti M, Orlando F et al (2018) The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry. Rheumatology (Oxford) 57(7):1203\u20131211. https:\/\/doi.org\/10.1093\/rheumatology\/key058","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"4886_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40272-017-0226-4","volume":"19","author":"A Taddio","year":"2017","unstructured":"Taddio A, Zennaro F, Pastore S, Cimaz R (2017) An Update on the pathogenesis and treatment of chronic recurrent multifocal osteomyelitis in children. Paediatr Drugs 19(3):165\u2013172. https:\/\/doi.org\/10.1007\/s40272-017-0226-4","journal-title":"Paediatr Drugs"},{"issue":"10","key":"4886_CR21","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/rheumatology\/keh295","volume":"43","author":"C Kerrison","year":"2004","unstructured":"Kerrison C, Davidson JE, Cleary AG, Beresford MW (2004) Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology (Oxford) 43(10):1246\u20131251. https:\/\/doi.org\/10.1093\/rheumatology\/keh295","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"4886_CR22","first-page":"1585","volume":"34","author":"S Compeyrot-Lacassagne","year":"2007","unstructured":"Compeyrot-Lacassagne S, Rosenberg AM, Babyn P, Laxer RM (2007) Pamidronate treatment of chronic noninfectious inflammatory lesions of the mandible in children. J Rheumatol 34(7):1585\u20131589","journal-title":"J Rheumatol"},{"key":"4886_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12969-018-0294-1","volume":"16","author":"M Oliver","year":"2018","unstructured":"Oliver M, Lee TC, Halpern-Felsher B et al (2018) Disease burden and social impact of pediatric chronic nonbacterial osteomyelitis from the patient and family perspective. Pediatr Rheumatol 16:78. https:\/\/doi.org\/10.1186\/s12969-018-0294-1","journal-title":"Pediatr Rheumatol"},{"issue":"9","key":"4886_CR24","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1002\/art.20464","volume":"50","author":"P Kopterides","year":"2004","unstructured":"Kopterides P, Pikazis D, Koufos C (2004) Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum 50(9):2970\u20132973. https:\/\/doi.org\/10.1002\/art.20464","journal-title":"Arthritis Rheum"},{"issue":"11","key":"4886_CR25","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3899\/jrheum.160256","volume":"43","author":"SR Hofmann","year":"2016","unstructured":"Hofmann SR, Schnabel A, R\u00f6sen-Wolff A, Morbach H, Girschick HJ, Hedrich CM (2016) Chronic nonbacterial osteomyelitis: pathophysiological concepts and current treatment strategies. J Rheumatol 43(11):1956\u20131964. https:\/\/doi.org\/10.3899\/jrheum.160256","journal-title":"J Rheumatol"},{"issue":"1","key":"4886_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12969-016-0109-1","volume":"14","author":"MR Roderick","year":"2016","unstructured":"Roderick MR, Shah R, Rogers V, Finn A, Ramanan AV (2016) Chronic recurrent multifocal osteomyelitis (CRMO)\u2014advancing the diagnosis. Pediatr Rheumatol Online J 14(1):47. https:\/\/doi.org\/10.1186\/s12969-016-0109-1","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"4886_CR27","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/art.39013","volume":"67","author":"J Wipff","year":"2015","unstructured":"Wipff J, Costantino F, Lemelle I, Pajot C, Duquesne A, Lorrot M, Faye A, Bader-Meunier B, Brochard K, Despert V, Jean S, Grall-Lerosey M, Marot Y, Nouar D, Pagnier A, Quartier P, Job-Deslandre C (2015) A large national cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumatol 67(4):1128\u20131137. https:\/\/doi.org\/10.1002\/art.39013","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"4886_CR28","doi-asserted-by":"publisher","first-page":"e1190","DOI":"10.1542\/peds.2011-3788","volume":"130","author":"A Borzutzky","year":"2012","unstructured":"Borzutzky A, Stern S, Reiff A, Zurakowski D, Steinberg EA, Dedeoglu F, Sundel RP (2012) Pediatric chronic nonbacterial osteomyelitis. Pediatrics 130(5):e1190\u2013e1197. https:\/\/doi.org\/10.1542\/peds.2011-3788","journal-title":"Pediatrics"},{"key":"4886_CR29","doi-asserted-by":"publisher","unstructured":"Marini JC (2003) Do bisphosphonates make children's bones better or brittle? N Engl J Med 349(5):423\u2013426. https:\/\/doi.org\/10.1056\/NEJMp038103","DOI":"10.1056\/NEJMp038103"},{"issue":"5","key":"4886_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1056\/NEJMoa023110","volume":"349","author":"MP Whyte","year":"2003","unstructured":"Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S (2003) Bisphosphonate-induced osteopetrosis. N Engl J Med 349(5):457\u2013463. https:\/\/doi.org\/10.1056\/NEJMoa023110","journal-title":"N Engl J Med"},{"key":"4886_CR31","doi-asserted-by":"publisher","unstructured":"Dwan K, Phillipi CA, Steiner RD, Basel D (2014) Bisphosphonate therapy for osteogenesis imperfect. Cochrane Database Syst Rev (7):CD005088. https:\/\/doi.org\/10.1002\/14651858.CD005088.pub3","DOI":"10.1002\/14651858.CD005088.pub3"},{"issue":"4","key":"4886_CR32","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00198-018-4791-3","volume":"30","author":"S Nayak","year":"2019","unstructured":"Nayak S, Greenspan SL (2019) A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk. Osteoporos Int 30(4):705\u2013720. https:\/\/doi.org\/10.1007\/s00198-018-4791-3","journal-title":"Osteoporos Int"},{"key":"4886_CR33","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12891-016-1167-8","volume":"17","author":"R Meinen","year":"2016","unstructured":"Meinen R, Galli-Lysak I, Villiger PM et al (2016) Influence of bisphosphonate therapy on bone geometry, volumetric bone density and bone strength of femoral shaft in postmenopausal women with rheumatoid arthritis. BMC Musculoskelet Disord 17:324. https:\/\/doi.org\/10.1186\/s12891-016-1167-8","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"4886_CR34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2165\/00002018-200932090-00002","volume":"32","author":"K Ing-Lorenzini","year":"2009","unstructured":"Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R (2009) Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital. Drug Saf 32(9):775\u2013785. https:\/\/doi.org\/10.2165\/00002018-200932090-00002","journal-title":"Drug Saf"},{"issue":"344","key":"4886_CR35","first-page":"1238","volume":"8","author":"K Ing Lorenzinit","year":"2012","unstructured":"Ing Lorenzinit K, Meier R, Suva D, Dayer P, Desmeules J, Peter R (2012) Atypical femoral fracture associated with the use of bisphosphonates, an adverse drug reaction not to be missed. Rev Med Suisse 8(344):1238\u20131242","journal-title":"Rev Med Suisse"},{"issue":"6","key":"4886_CR36","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/MED.0000000000000287","volume":"23","author":"RA Adler","year":"2016","unstructured":"Adler RA (2016) Bisphosphonates and atypical femoral fractures. Curr Opin Endocrinol Diabetes Obes 23(6):430\u2013434. https:\/\/doi.org\/10.1097\/MED.0000000000000287","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"4886_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1592\/phco.24.2.195.33143","volume":"24","author":"RE Robinson","year":"2004","unstructured":"Robinson RE, Nahata MC, Hayes JR, Batisky DL, Bates CM, Mahan JD (2004) Effectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescents. Pharmacotherapy 24(2):195\u2013197. https:\/\/doi.org\/10.1592\/phco.24.2.195.33143","journal-title":"Pharmacotherapy"},{"key":"4886_CR38","doi-asserted-by":"publisher","unstructured":"Thi\u00e9baud D, Sauty A, Burckhardt P, Leuenberger P, Sitzler L, Green JR, Kandra A, Zieschang J, Ibarra de Palacios P (1997) An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int 61(5):386\u2013392. https:\/\/doi.org\/10.1007\/s002239900353","DOI":"10.1007\/s002239900353"},{"issue":"12","key":"4886_CR39","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00198-005-1986-1","volume":"16","author":"BA Barrera","year":"2005","unstructured":"Barrera BA, Wilton L, Harris S, Shakir SA (2005) Prescription-event monitoring study on 13,164 patients prescribed rise dronate in primary care in England. Osteoporos Int 16(12):1989\u20131998. https:\/\/doi.org\/10.1007\/s00198-005-1986-1","journal-title":"Osteoporos Int"},{"issue":"6","key":"4886_CR40","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1681\/ASN.V1261164","volume":"12","author":"GS Markowitz","year":"2001","unstructured":"Markowitz GS, Appel GB, Fine PL, Fenves AZ, Loon NR, Jagannath S, Kuhn JA, Dratch AD, D\u2019Agati VD (2001) Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 12(6):1164\u20131172","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4886_CR41","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1093\/annonc\/mdj105","volume":"17","author":"T Tanvetyanon","year":"2006","unstructured":"Tanvetyanon T, Stiff PJ (2006) Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 17(6):897\u2013907. https:\/\/doi.org\/10.1093\/annonc\/mdj105","journal-title":"Ann Oncol"},{"issue":"2","key":"4886_CR42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/s0002-9394(14)72902-2","volume":"118","author":"V Macarol","year":"1994","unstructured":"Macarol V, Fraunfelder FT (1994) Pamidronate disodium and possible ocular adverse drug reactions. Am J Ophthalmol 118(2):220\u2013224. https:\/\/doi.org\/10.1016\/s0002-9394(14)72902-2","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"4886_CR43","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1023\/a:1005574009856","volume":"45","author":"LM Lichtenberger","year":"2000","unstructured":"Lichtenberger LM, Romero JJ, Gibson GW, Blank MA (2000) Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa. Dig Dis Sci 45(9):1792\u20131801. https:\/\/doi.org\/10.1023\/a:1005574009856","journal-title":"Dig Dis Sci"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04886-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04886-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04886-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T14:27:04Z","timestamp":1647959224000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04886-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["4886"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04886-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"15 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared that they had no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval was not required to conduct this survey.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants consented to participate in this survey.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}